Cargando…
Clinician Perspectives on Monoclonal Antibody Treatment for High-Risk Outpatients with COVID-19: Implications for Implementation and Equitable Access
BACKGROUND: There is an urgent need to identify and address factors influencing uptake and equitable access to monoclonal antibody (mAb) treatment for high-risk outpatients with COVID-19. OBJECTIVE: To assess clinician knowledge, beliefs, and experiences regarding obtaining mAb treatment for eligibl...
Autores principales: | Kwan, Bethany M., Sobczak, Chelsea, Beaty, Laurel, Wynia, Matthew K., DeCamp, Matthew, Owen, Vanessa, Ginde, Adit A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255528/ https://www.ncbi.nlm.nih.gov/pubmed/35790666 http://dx.doi.org/10.1007/s11606-022-07702-2 |
Ejemplares similares
-
“All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19
por: Kwan, Bethany M., et al.
Publicado: (2022) -
Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives
por: Hamer, Mika K., et al.
Publicado: (2022) -
A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients
por: Fish, Lindsey E., et al.
Publicado: (2023) -
Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
por: Wynia, Matthew K., et al.
Publicado: (2023) -
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
por: Douin, David J., et al.
Publicado: (2022)